Founded in 1980, Atlas Venture is a venture capital firm based in Cambridge, Massachusetts. The firm seeks to invest in the life sciences, biotechnology, and drug discovery sectors.
Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
---|---|---|---|---|---|---|
Scorpion Therapeutics | 07-Jan-2021 | Early Stage VC | 00000 | Drug Discovery | Startup | 0000-00000000 0000000 00 |
00000 00000000 | 05-Jan-2021 | 00000 00000 | 00000 | Drug Discovery | Clinical Trials - Phase 1 | 0000-00000000 0000000 00 |
00000 000000000000 | 08-Dec-2020 | 00000 00000 | 0000 | Drug Discovery | Startup | 00000 000000000 00.0 |
0000000 0000000000 | 30-Nov-2020 | 00000 00000 | 0000 | Drug Discovery | Startup | 00000 000000000 00.0 |
00000000000 | 09-Nov-2020 | 00000 00000 | 00.00 | Entertainment Software | Generating Revenue | |
000 000 | 29-Oct-2020 | 00000 00000 | 0000 | Drug Discovery | Clinical Trials - Phase 1 | 00000 0000000 00 |
00000000 000000000 | 26-Oct-2020 | 00000 00000 | 00000 | Drug Discovery | Startup | 0000-00000000 0000000 00 |
00 000000000 | 22-Oct-2020 | 00000 00000 | 0000 | Drug Discovery | Generating Revenue | 00000 000000 |
Gemini Therapeutics | 15-Oct-2020 | PIPE | 0000 | Drug Discovery | Generating Revenue | 00000 000000 |
Vigil Neuroscience | 05-Oct-2020 | Early Stage VC | 000.00 | Other Healthcare Services | Stealth | 00000 00000 00.0 |
Company Name | Exit Date | Exit Type | Exit Size |
---|---|---|---|
Generation Bio | 07-Jan-2021 | Public Investment 2nd Offering | 00000 |
000000 | 17-Dec-2020 | 0000000 000000 | |
0000000 000000 | 10-Dec-2020 | 000 | 00000 |
0-0000 00000000000 | 22-Nov-2020 | 0000000 000000 | |
0000000000 | 08-Oct-2020 | 000000 0000000000 | 00.000 |
0000 000000000000 | 17-Sep-2020 | 000 | 00000 |
000000 | 01-Sep-2020 | 000000000000000000 | 00000 |
000000 00000000000 | 21-Aug-2020 | 000 | 00000 |
DisplayLink | 31-Jul-2020 | Merger/Acquisition | 00000 |
Akero Therapeutics | 09-Jul-2020 | Public Investment 2nd Offering | 00000 |
Fund Name | Vintage | Size | Dry Powder | DPI | RVPI | TVPI | IRR |
---|
This information is available in the PitchBook Platform. To explore Atlas Venture‘s full profile, request access.
Request a free trialInvestments by Industry
Investments by Year
Investments by Region
PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.
Request a free trialName | Title | Deals | Funds | Boards | Office |
---|---|---|---|---|---|
Rajesh Devraj Ph.D | Venture Partner | 0 | Cambridge, MA | ||
David Grayzel MD | Partner | 0 | 0 | 0 | Cambridge, MA |
Jason Rhodes | Partner | 00 | 0 | 0 | Cambridge, MA |
Jean-Francois Formela MD | Partner | 00 | 00 | 00 | Cambridge, MA |
Michael Gladstone | Partner | 0 | 0 | 0 | Cambridge, MA |
Name | With | Exits | Lead Partner | Series | Industry |
---|---|---|---|---|---|
Alexandria Venture Investments | 6 | 0 |
![]() |
![]() |
|
Citadel (Hedge Fund) | 0 | 0 |
![]() |
![]() |
|
Cormorant Asset Management | 0 | 0 |
![]() |
![]() |
|
GV | 0 | 0 | 0 |
![]() |
![]() |
OrbiMed | 0 | 0 |
![]() |
![]() |